2018年《肝硬化肝性脑病诊疗指南》更新要点解读

李小科; 王姗; 李志国; 甘大楠; 叶永安

doi:10.3969/j.issn.1001-5256.2019.07.012

2018年《肝硬化肝性脑病诊疗指南》更新要点解读

DOI: 10.3969/j.issn.1001-5256.2019.07.012

北京中医药大学东直门医院消化科北京中医药大学肝病研究所

基金项目:

北京中医药大学东直门医院“111”协同创新院际合作项目(2016-DZM111-JC016);北京中医药大学科研创新团队项目(2019-JYB-TD-009)；

详细信息

中图分类号: R575.2;R747.9
计量
- 文章访问数: 1686
- HTML全文浏览量: 66
- PDF下载量: 727
- 被引次数: 0
出版历程
- 收稿日期: 2019-01-23
- 出版日期: 2019-07-20

Updated key points of Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis ( 2018)

Department of Gastroenterology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine & Institute of Liver Diseases, Beijing University of Chinese Medicine

Research funding:

摘要

摘要: 2018年中华医学会肝病学分会发布了《肝硬化肝性脑病诊疗指南》,为肝性脑病包括轻微型肝性脑病的临床诊断和治疗提出推荐性意见,具有重要的指导意义。与2013年中国《肝性脑病诊治共识意见(2013年,重庆)》、2014年美国肝脏病学会与欧洲肝脏病学会颁布的《2014年AASLD/EASL慢性肝病肝性脑病实践指南》相比,新版指南在肝性脑病的分级、诊断、治疗等方面有较多更新亮点。归纳了此指南的更新要点,以期细化理解新版指南对临床治疗的指导作用,提高诊疗水平。
- 肝性脑病 /
- 诊断 /
- 治疗学 /
- 诊疗准则(主题)
Abstract: In 2018, Chinese Society of Hepatology, Chinese Medical Association, issued Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis, which gives recommendations for the clinical diagnosis and treatment of hepatic encephalopathy including minimal hepatic encephalopathy and has important guiding significance. Compared with Consensus on the diagnosis and treatment of hepatic encephalopathy in China ( Chongqing, 2013) and Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, the updated guidelines have several new points in the classification, diagnosis, and treatment of hepatic encephalopathy. This article summarizes the updated key points in the guidelines, so as to understand the effect of the guidelines in guiding clinical treatment and improve diagnosis and treatment.
- hepatic encephalopathy /
- diagnosis /
- therapeutics /
- practice guidelines as topic

HTML全文

参考文献(24)

[1]Chinese Society of Gastroenterology and Chinese Society of Hepatology, Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013) [J/CD].Chin J Front Med Sci:Electronic Version, 2014, 6 (2) :81-93. (in Chinese) 中华医学会消化病学分会, 中华医学会肝病学分会.中国肝性脑病诊治共识意见 (2013年, 重庆) [J/CD].中国医学前沿杂志:电子版, 2014, 6 (2) :81-93.

[2]HENDRIK V, PIERO A, JASMOHAN B, et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the american association for the study of liver diseases and the European Association for the Study of the Liver[J].Hepatology, 2014, 60 (2) :715-735.

[3]ZHANG Y, LIU W, ZHANG FK.Recommendations on hepatic encephalopathy in chronic liver disease:2014 practice guideline by the European Associ ation for the Study of the Liver and the American Association for the Study of Liver Diseases[J].JClin Hepatol, 2014, 30 (8) :719-721. (in Chinese) 张影, 刘威, 张福奎.2014年美国肝病学会和欧洲肝病学会对慢性肝病时肝性脑病实践指南的建议要点[J].临床肝胆病杂志, 2014, 30 (8) :719-721.

[4]Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of hepatic encephalopathy in cirrhosis[J].J Clin Hepatol, 2018, 34 (10) :2076-2089. (in Chinese) 中华医学会肝病学分会.肝硬化肝性脑病诊疗指南[J].临床肝胆病杂志, 2018, 34 (10) :2076-2089.

[5]JIA JP, CHEN SD.Neurology[M].7th, Beijing:People's Medical Publishing House, 2013:9-14. (in Chinese) 贾建平, 陈生弟.神经病学[M].7版, 北京:人民卫生出版社, 2013:9-14.

[6]CHENG F, CAO HY, WU XR, et al.Latent class model of inducing factors of hepatic encephalopathy and high-risk population screening[J].Chron Pathematol J, 2018, 19 (1) :4-7, 11. (in Chinese) 程璠, 曹红艳, 武希润, 等.肝性脑病诱发因素的潜在类别模型与高危人群筛选[J].慢性病学杂志, 2018, 19 (1) :4-7, 11.

[7]TSAI CF, CHEN MH, WANG YP, et al.Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study[J].Gastroenterology, 2017, 152 (1) :134-141.

[8] SCHULZ C, SCHUTTE K, REISENER N, et al.Prevalence of Helicobacter pylori infection in patients with minimal hepatic encephalopathy[J].J Gastrointestin Liver Dis, 2016, 25 (2) :191-195.

[9]HU BL, WANG HY, YANG GY.Association of Helicobacter pylori infection with hepatic encephalopathy risk:A systematicreview[J].Clin Res Hepatol Gastroenterol, 2013, 37 (6) :619-625.

[10]SCHULZ C, SCHUTTE K, MALFERTHEINER P.Does H.pylori eradication therapy benefit patients with hepatic encephalopathy?:Systematic review[J].J Clin Gastroenterol, 2014, 48 (6) :491-499.

[11]WANG AJ, PENG AP, LI BM, et al.Natural history of covert hepatic encephalopathy:An observational study of 366 cirrhotic patients[J].World J Gastroenterol, 2017, 23 (34) :6321-6329.

[12]FORMENTIN C, de RUI M, ZONCAPE M, et al.The Psychomotor Vigilance Task:Role in the diagnosis of hepatic encephalopathy and relationship with driving ability[J].J Hepatol, 2019, 70 (4) :648-657.

[13]CHEN DF, SUN WJ.New concept of hepatic encephalopathy:From guideline to clinical practice[J].J Pract Hepatol, 2016, 19 (1) :16-19. (in Chinese) 陈东风, 孙文静.肝性脑病的新认识-从指南到临床[J].实用肝脏病杂志, 2016, 19 (1) :16-19.

[14]CAMPAGNA F, MONTAGNESE S, RIDOLA L, et al.The animal naming test:An easy tool for the assessment of hepatic encephalopathy[J].Hepatology, 2017, 66 (1) :198-208.

[15]URIOS A, MANGAS-LOSADA A, GIMENEZ-GARZO C, et al.Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits[J].Liver Int, 2017, 37 (7) :1013-1022.

[16]SEO K, JUN DW, KIM JK, et al.Multi-sensory integration impairment in patients with minimal hepatic encephalopathy[J].Sci Rep, 2017, 7 (1) :14947.

[17]BAJAJ JS, HEUMAN DM, STERLING RK, et al.Validation of encephal App, smartphone-based stroop test, for the diagnosis of covert hepatic encephalopathy[J].Clin Gastroenterol Hepatol, 2015, 13 (10) :1828-1835.

[18]XIE JT, LIU SC.Application of Propofol in the manic phase of hepatic encephalopathy[J].China Foreign Med Treatment, 2016, 35 (27) :131-134. (in Chinese) 谢家泰, 刘思纯.丙泊酚在肝性脑病狂躁期中的应用分析[J].中外医疗, 2016, 35 (27) :131-134.

[19]LIU Q, CAI KY.Advances in the treatment of hepatic encephalopathy with traditional Chinese medicine[J].Mil Med J SChin, 2018, 32 (2) :142-143, 145. (in Chinese) 刘琼, 蔡克银.中医药治疗肝性脑病的研究进展[J].华南国防医学杂志, 2018, 32 (2) :142-143, 145.

[20]WEN LN, LI SF, GUO Z, et al.Awaking decoction retention enema combined with western medicine in the treatment of hepatic encephalopathy[J].J Changchun Univ Chin Med, 2018, 34 (3) :522-524. (in Chinese) 问莉娜, 李淑芳, 郭珍, 等.促醒汤保留灌肠联合西药治疗肝性脑病[J].长春中医药大学学报, 2018, 34 (3) :522-524.

[21]WIJARNPREECHA K, CHESDACHAI S, THONGPRAYOON C, et al.Association of helicobacter pylori with the risk of hepatic encephalopathy[J].Dig Dis Sci, 2017, 62 (12) :3614-3621.

[22] HU BL, WANG HY, YANG GY.Association of Helicobacter pylori infection with hepatic encephalopathy risk:A systematicreview[J].Clin Res Hepatol Gastroenterol, 2013, 37 (6) :619-625.

[23]SCHULZ C, SCHUTTE K, REISENER N, et al.Prevalence of Helicobacter pylori infection in patients with minimal hepatic encephalopathy[J].J Gastrointestin Liver Dis, 2016, 25 (2) :191-195.

[24]GAN XM, LI W.Nutrition support therapy for patients with hepatic encephalopathy[J].J Clin Hepatol, 2016, 32 (1) :178-181. (in Chinese) 甘雪梅, 李武.肝性脑病患者的营养支持治疗[J].临床肝胆病杂志, 2016, 32 (1) :178-181.

施引文献

资源附件(0)

访问统计